The mechanisms of cancer immunoescape and development of overcoming strategies

Tomonori Yaguchi, Hidetoshi Sumimoto, Chie Kudo-Saito, Nobuo Tsukamoto, Ryo Ueda, Tomoko Iwata-Kajihara, Hiroshi Nishio, Naoshi Kawamura, Yutaka Kawakami

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

Cancer-induced immunosuppression is a major problem as it reduces the anti-tumor effects of immunotherapies. In cancer tissues, cancer cells, immune cells, and other stromal cells interact and create an immunosuppressive microenvironment through a variety of immunosuppressive factors. Some cancer subpopulations such as cancer cells undergoing epithelial-mesenchymal transition and cancer stem-like cells have immunosuppressive and immunoresistant properties. The production of immunosuppressive factors by cancer cells is mechanistically attributed to oncogenic signals frequently activated in cancer cells, including the STAT3, MAPK, NF-κB, and Wnt/β-catenin signals, which are upstream events leading to immunosuppressive cascades. Moreover, some of these signals are also activated in immunosuppressive immune cells stimulated by cancer-derived factors and contribute to their immunosuppressive activities. Therefore, targeting these signals both in cancer cells and immunosuppressive immune cells may result in the restoration of immuno-competence in cancer patients and improve current immunotherapy.

Original languageEnglish
Pages (from-to)294-300
Number of pages7
JournalInternational Journal of Hematology
Volume93
Issue number3
DOIs
Publication statusPublished - 2011 Mar

Fingerprint

Immunosuppressive Agents
Neoplasms
Immunotherapy
Catenins
Epithelial-Mesenchymal Transition
Neoplastic Stem Cells
Stromal Cells
Mental Competency
Immunosuppression

Keywords

  • Cancer immunotherapy
  • Cancer stem cell
  • EMT
  • Immunosuppression
  • Mesenchymal stem cell
  • Oncogenic signal

ASJC Scopus subject areas

  • Hematology

Cite this

The mechanisms of cancer immunoescape and development of overcoming strategies. / Yaguchi, Tomonori; Sumimoto, Hidetoshi; Kudo-Saito, Chie; Tsukamoto, Nobuo; Ueda, Ryo; Iwata-Kajihara, Tomoko; Nishio, Hiroshi; Kawamura, Naoshi; Kawakami, Yutaka.

In: International Journal of Hematology, Vol. 93, No. 3, 03.2011, p. 294-300.

Research output: Contribution to journalArticle

Yaguchi, T, Sumimoto, H, Kudo-Saito, C, Tsukamoto, N, Ueda, R, Iwata-Kajihara, T, Nishio, H, Kawamura, N & Kawakami, Y 2011, 'The mechanisms of cancer immunoescape and development of overcoming strategies', International Journal of Hematology, vol. 93, no. 3, pp. 294-300. https://doi.org/10.1007/s12185-011-0799-6
Yaguchi, Tomonori ; Sumimoto, Hidetoshi ; Kudo-Saito, Chie ; Tsukamoto, Nobuo ; Ueda, Ryo ; Iwata-Kajihara, Tomoko ; Nishio, Hiroshi ; Kawamura, Naoshi ; Kawakami, Yutaka. / The mechanisms of cancer immunoescape and development of overcoming strategies. In: International Journal of Hematology. 2011 ; Vol. 93, No. 3. pp. 294-300.
@article{f3fbbbf31a8e41bf855b442ca42f77af,
title = "The mechanisms of cancer immunoescape and development of overcoming strategies",
abstract = "Cancer-induced immunosuppression is a major problem as it reduces the anti-tumor effects of immunotherapies. In cancer tissues, cancer cells, immune cells, and other stromal cells interact and create an immunosuppressive microenvironment through a variety of immunosuppressive factors. Some cancer subpopulations such as cancer cells undergoing epithelial-mesenchymal transition and cancer stem-like cells have immunosuppressive and immunoresistant properties. The production of immunosuppressive factors by cancer cells is mechanistically attributed to oncogenic signals frequently activated in cancer cells, including the STAT3, MAPK, NF-κB, and Wnt/β-catenin signals, which are upstream events leading to immunosuppressive cascades. Moreover, some of these signals are also activated in immunosuppressive immune cells stimulated by cancer-derived factors and contribute to their immunosuppressive activities. Therefore, targeting these signals both in cancer cells and immunosuppressive immune cells may result in the restoration of immuno-competence in cancer patients and improve current immunotherapy.",
keywords = "Cancer immunotherapy, Cancer stem cell, EMT, Immunosuppression, Mesenchymal stem cell, Oncogenic signal",
author = "Tomonori Yaguchi and Hidetoshi Sumimoto and Chie Kudo-Saito and Nobuo Tsukamoto and Ryo Ueda and Tomoko Iwata-Kajihara and Hiroshi Nishio and Naoshi Kawamura and Yutaka Kawakami",
year = "2011",
month = "3",
doi = "10.1007/s12185-011-0799-6",
language = "English",
volume = "93",
pages = "294--300",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - The mechanisms of cancer immunoescape and development of overcoming strategies

AU - Yaguchi, Tomonori

AU - Sumimoto, Hidetoshi

AU - Kudo-Saito, Chie

AU - Tsukamoto, Nobuo

AU - Ueda, Ryo

AU - Iwata-Kajihara, Tomoko

AU - Nishio, Hiroshi

AU - Kawamura, Naoshi

AU - Kawakami, Yutaka

PY - 2011/3

Y1 - 2011/3

N2 - Cancer-induced immunosuppression is a major problem as it reduces the anti-tumor effects of immunotherapies. In cancer tissues, cancer cells, immune cells, and other stromal cells interact and create an immunosuppressive microenvironment through a variety of immunosuppressive factors. Some cancer subpopulations such as cancer cells undergoing epithelial-mesenchymal transition and cancer stem-like cells have immunosuppressive and immunoresistant properties. The production of immunosuppressive factors by cancer cells is mechanistically attributed to oncogenic signals frequently activated in cancer cells, including the STAT3, MAPK, NF-κB, and Wnt/β-catenin signals, which are upstream events leading to immunosuppressive cascades. Moreover, some of these signals are also activated in immunosuppressive immune cells stimulated by cancer-derived factors and contribute to their immunosuppressive activities. Therefore, targeting these signals both in cancer cells and immunosuppressive immune cells may result in the restoration of immuno-competence in cancer patients and improve current immunotherapy.

AB - Cancer-induced immunosuppression is a major problem as it reduces the anti-tumor effects of immunotherapies. In cancer tissues, cancer cells, immune cells, and other stromal cells interact and create an immunosuppressive microenvironment through a variety of immunosuppressive factors. Some cancer subpopulations such as cancer cells undergoing epithelial-mesenchymal transition and cancer stem-like cells have immunosuppressive and immunoresistant properties. The production of immunosuppressive factors by cancer cells is mechanistically attributed to oncogenic signals frequently activated in cancer cells, including the STAT3, MAPK, NF-κB, and Wnt/β-catenin signals, which are upstream events leading to immunosuppressive cascades. Moreover, some of these signals are also activated in immunosuppressive immune cells stimulated by cancer-derived factors and contribute to their immunosuppressive activities. Therefore, targeting these signals both in cancer cells and immunosuppressive immune cells may result in the restoration of immuno-competence in cancer patients and improve current immunotherapy.

KW - Cancer immunotherapy

KW - Cancer stem cell

KW - EMT

KW - Immunosuppression

KW - Mesenchymal stem cell

KW - Oncogenic signal

UR - http://www.scopus.com/inward/record.url?scp=79955829822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955829822&partnerID=8YFLogxK

U2 - 10.1007/s12185-011-0799-6

DO - 10.1007/s12185-011-0799-6

M3 - Article

C2 - 21374075

AN - SCOPUS:79955829822

VL - 93

SP - 294

EP - 300

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 3

ER -